The School of Natural Sciences
Harnessing the power of hematopoietic stem cells in immunity against TB
Nargis Khan, Ph.D.
Department of Medicine
Friday, June 4th, 2021
To Zoom in, please use this link: https://ucmerced.zoom.us/j/89376226981
Mycobacterium tuberculosis (Mtb) is primarily a respiratory pathogen. However, the growth of Mtb is not limited to the lungs but also disseminate to peripheral lymphoid organs and even the bone marrow (BM). Considering the BM is home to hematopoietic stem cells (HSCs), the earliest precursor of immune cells including monocytes and macrophages, translocation of Mtb to this privileged site may have significant consequences on the pathogenesis and chronicity of TB. Interestingly, BM suppression in TB was documented in the late 1980s, and it has been shown that Mtb persists in the BM by exploiting mesenchymal stem cells as a niche for its survival. However, the effect of Mtb on HSC function and the subsequent immune response are incompletely understood. In this study we have demonstrated the impact of Mtb on the hematopoiesis in the BM and its consequences on trained immunity. Accesses of Mtb in the BM specifically target innate immunity via imprinting HSC populations with a unique transcriptomic profile that suppresses myelopoiesis and generates impaired trained immunity via IFN-I/iron axis to promote Mtb infection.
Dr. Nargis Khan completed her PhD at IMTECH-Jawaharlal Nehru University, New Delhi, India. Currently, she is a postdoctoral fellow with Dr. Maziar Divangahi at Meakins-Christie Laboratories at MUHC, McGill University. Her PDF research study at McGill is focused on three conceptual frameworks of immunity to TB: Host Resistance, Disease tolerance and Trained immunity. Through her PDF program, she has been a proliferative investigator with outstanding publications in Cell, Science Immunology, Mucosal Immunology. She received numerous awards, including FRQS and CIHR.
For more information, please contact:
Prof. Michele Nishiguchi at email@example.com.